Abbott Molecular can Impact
Every Step of the Oncology
Patient Journey
Scientific advancements for cancer patients are quickly evolving and more promising than ever before. At the heart of today’s complex and highly personalized approach to cancer is molecular diagnostics. Abbott Molecular is a pioneer and leader in oncology molecular diagnostics with its Vysis FISH assays and Abbott RealTime IDH1 and IDH2 assays.